Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Cross Country Healthcare, Inc. (CCRN) has a Wall Street consensus price target of $9.93, based on estimates from 13 covering analysts. With the stock currently trading at $8.70, this represents a potential upside of +14.1%. The company has a market capitalization of $281M.
Analyst price targets range from a low of $8.65 to a high of $11.00, representing a 24% spread in expectations. The median target of $10.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,10 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CCRN trades at a trailing P/E of -19.8x and forward P/E of 106.4x. Analysts expect EPS to grow +117.0% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CCRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonCross Country Healthcare, Inc. (CCRN) has a consensus 12-month price target of $9.93, implying 14.1% upside from $8.7. The 13 analysts covering CCRN see moderate appreciation potential.
CCRN has a consensus rating of "Hold" based on 13 Wall Street analysts. The rating breakdown is mixed, with 10 Hold ratings making up the largest segment. The consensus 12-month price target of $9.93 implies 14.1% upside from current levels.
At a forward P/E of 106.357x, CCRN trades at a premium valuation. The consensus price target of $9.93 (14.1% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $11 for CCRN, while the most conservative target is $8.65. The consensus of $9.93 represents the median expectation. These targets typically reflect 12-month expectations.
CCRN is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 10 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CCRN stock forecast based on 13 Wall Street analysts shows a consensus price target of $9.93, with estimates ranging from $8.65 (bear case) to $11 (bull case). The median consensus rating is "Hold".
CCRN trades at a forward P/E ratio of 106.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CCRN, with a "Hold" consensus rating and $9.93 price target (14.1% upside). 3 of 13 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CCRN analyst price targets range from $8.65 to $11, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9.93 consensus represents the middle ground.